Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH.

Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.

This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.

LATEST FROM THE BLOG

New Study at CWMH: A Neurosteroid Intervention for Menopausal and Perimenopausal Depression

MGH Center for Women's Mental Health2018-10-17T17:52:57+00:00October 17th, 2018|

Women are twice as likely as men to have major depressive disorder (MDD) during their lifetimes, and women are particularly at risk during the menopausal […]

In Brief: More Data on Pregabalin (Lyrica) and Pregnancy

MGH Center for Women's Mental Health2018-10-05T20:26:46+00:00October 16th, 2018|

Pregabalin (marketed in the US as Lyrica) is approved by the US Food and Drug Administration for the treatment […]

New Study at CWMH: Genetics of Postpartum Psychosis – Massachusetts General Hospital Postpartum Psychosis Project (MGHP3)

MGH Center for Women's Mental Health2018-10-10T16:09:27+00:00October 10th, 2018|

Postpartum psychosis (PPP) is a rare but serious condition, occurring in 1 to 2 per 1000 women in the weeks after delivery and associated with […]

Project TEACH and the NY State Conference on Maternal Depression

MGH Center for Women's Mental Health2018-10-08T16:04:18+00:00October 9th, 2018|

Our group will be traveling to Albany, New York this Friday, October 12th, to take part in the New York […]

VIEW ALL RECENT BLOG POSTS

The National
Pregnancy Registry
for Psychiatric Medications:

All pregnant women between the ages of 18-45 with a history of psychiatric illness are eligible to enroll in the registry.

LEARN MORE

MGH Perinatal Depression Scale Mobile App

Are you pregnant? Do you own a smart phone? Get the MGH Perinatal Depression Scale app.

LEARN MORE

RESEARCH STUDIES

National Pregnancy Registry for Psychiatric Medications©

The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, stimulants, and atypical antipsychotics that many women take during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders.

A Neurosteroid Intervention for Menopausal and Perimenopausal Depession

Are you experiencing symptoms of menopause and feeling depressed or down? You may be eligible for a research study at Massachusetts General Hospital evaluating how a medication treats menopausal depression and other symptoms of menopause.

Course of ADHD in Pregnancy and the Postpartum

Are you pregnant? Do you have a history of ADHD? You may be eligible to take part in an observational research study for women discontinuing psychostimulants during pregnancy and the postpartum.

VIEW ALL